Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
31 08 2021
Historique:
pubmed: 11 8 2021
medline: 15 9 2021
entrez: 10 8 2021
Statut: ppublish

Résumé

The 2',5'-oligoadenylate (2-5A)-dependent endoribonuclease, RNase L, is a principal mediator of the interferon (IFN) antiviral response. Therefore, the regulation of cellular levels of 2-5A is a key point of control in antiviral innate immunity. Cellular 2-5A levels are determined by IFN-inducible 2',5'-oligoadenylate synthetases (OASs) and by enzymes that degrade 2-5A. Importantly, many coronaviruses (CoVs) and rotaviruses encode 2-5A-degrading enzymes, thereby antagonizing RNase L and its antiviral effects. A-kinase-anchoring protein 7 (AKAP7), a mammalian counterpart, could possibly limit tissue damage from excessive or prolonged RNase L activation during viral infections or from self-double-stranded RNAs that activate OAS. We show that these enzymes, members of the two-histidine phosphoesterase (2H-PE) superfamily, constitute a subfamily referred here as 2',5'-PEs. 2',5'-PEs from the mouse CoV mouse hepatitis virus (MHV) (NS2), Middle East respiratory syndrome coronavirus (MERS-CoV) (NS4b), group A rotavirus (VP3), and mouse (AKAP7) were investigated for their evolutionary relationships and activities. While there was no activity against 3',5'-oligoribonucleotides, they all cleaved 2',5'-oligoadenylates efficiently but with variable activity against other 2',5'-oligonucleotides. The 2',5'-PEs are shown to be metal ion-independent enzymes that cleave trimer 2-5A (2',5'-p

Identifiants

pubmed: 34372695
doi: 10.1128/mBio.01781-21
pmc: PMC8406329
doi:

Substances chimiques

A Kinase Anchor Proteins 0
Adenine Nucleotides 0
Akap7 protein, mouse 0
Oligoribonucleotides 0
2',5'-oligoadenylate 61172-40-5
Interferons 9008-11-1
Endoribonucleases EC 3.1.-
2-5A-dependent ribonuclease EC 3.1.26.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0178121

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI104887
Pays : United States
Organisme : Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
ID : AI104887
Organisme : Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
ID : AI140442
Organisme : NIAID NIH HHS
ID : R01 AI140442
Pays : United States
Organisme : Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
ID : AI135922
Organisme : NIAID NIH HHS
ID : R01 AI135922
Pays : United States

Références

J Virol. 2014 Aug;88(16):9072-85
pubmed: 24899176
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nucleic Acids Res. 2018 Nov 30;46(21):11488-11501
pubmed: 30215753
mBio. 2016 Mar 29;7(2):e00258
pubmed: 27025250
Biochimie. 2012 May;94(5):1098-107
pubmed: 22285541
Cell. 1993 Mar 12;72(5):753-65
pubmed: 7680958
Proc Natl Acad Sci U S A. 1978 Jan;75(1):256-60
pubmed: 272640
J Biol Chem. 2004 Sep 3;279(36):37832-41
pubmed: 15231837
J Interferon Cytokine Res. 2002 Sep;22(9):981-93
pubmed: 12396720
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
pubmed: 11585785
J Virol. 2017 Feb 14;91(5):
pubmed: 28003490
Cell Host Microbe. 2012 Jun 14;11(6):607-16
pubmed: 22704621
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E89-98
pubmed: 23236145
J Interferon Cytokine Res. 2011 Jan;31(1):41-7
pubmed: 21142819
Infect Genet Evol. 2013 Mar;14:58-67
pubmed: 23237956
BMC Biotechnol. 2004 Feb 26;4:2
pubmed: 15070414
Biochem Biophys Res Commun. 1981 May 29;100(2):847-56
pubmed: 6268077
Cell Host Microbe. 2015 Apr 8;17(4):466-77
pubmed: 25816776
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13114-9
pubmed: 23878220
Nat Rev Mol Cell Biol. 2020 Sep;21(9):501-521
pubmed: 32424334
PLoS Pathog. 2018 Jan 25;14(1):e1006838
pubmed: 29370303
Nature. 1977 Aug 11;268(5620):537-40
pubmed: 560630
Nucleic Acids Res. 2002 Dec 1;30(23):5229-43
pubmed: 12466548
J Exp Med. 2020 May 4;217(5):
pubmed: 32232339
mBio. 2014 Jul 01;5(4):e01312-14
pubmed: 24987090
Cell. 2019 Nov 27;179(6):1264-1275.e13
pubmed: 31778653
Eur J Biochem. 1982 Mar 1;122(3):601-8
pubmed: 6277637
Nucleic Acids Res. 2014 Apr;42(8):5202-16
pubmed: 24500209
Cell Host Microbe. 2017 Aug 9;22(2):176-184
pubmed: 28799903
Nucleic Acids Res. 2011 Sep 1;39(17):7750-63
pubmed: 21666256
EMBO J. 2020 Jun 2;39(11):e101573
pubmed: 32323871
Virology. 1999 Dec 5;265(1):120-30
pubmed: 10603323
Mol Cell. 2003 Nov;12(5):1173-85
pubmed: 14636576
Methods Enzymol. 2001;342:10-20
pubmed: 11586885
J Exp Med. 1997 Sep 15;186(6):967-72
pubmed: 9294150
Cell Mol Life Sci. 2000 Oct;57(11):1593-612
pubmed: 11092454
Nucleic Acids Res. 2011 May;39(9):3754-70
pubmed: 21245038
Elife. 2017 Mar 31;6:
pubmed: 28362255
J Interferon Cytokine Res. 2014 Jun;34(6):455-63
pubmed: 24905202
Biochimie. 2019 Jan;156:181-195
pubmed: 30195052
J Virol. 2020 Apr 16;94(9):
pubmed: 32051268
J Biol Chem. 1994 May 13;269(19):14153-8
pubmed: 7514601
Nature. 2020 Dec;588(7836):169-173
pubmed: 33087935
EMBO J. 1997 Nov 3;16(21):6355-63
pubmed: 9351818
mBio. 2019 Nov 12;10(6):
pubmed: 31719180
Arch Biochem Biophys. 2011 Aug 1;512(1):1-23
pubmed: 21640700
Cell. 2018 Feb 8;172(4):811-824.e14
pubmed: 29395325
Nat Rev Drug Discov. 2007 Dec;6(12):975-90
pubmed: 18049472
Sci Rep. 2018 Nov 2;8(1):16294
pubmed: 30389976
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5071-5076
pubmed: 30814222
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):
pubmed: 33811184
J Biol Chem. 2015 Aug 7;290(32):19681-96
pubmed: 26055709
Cell. 1978 Mar;13(3):565-72
pubmed: 657268
Nature. 2007 Aug 16;448(7155):816-9
pubmed: 17653195
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15623-8
pubmed: 9861020

Auteurs

Abhishek Asthana (A)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinicgrid.239578.2 Foundation, Cleveland, Ohio, USA.

Christina Gaughan (C)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinicgrid.239578.2 Foundation, Cleveland, Ohio, USA.

Beihua Dong (B)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinicgrid.239578.2 Foundation, Cleveland, Ohio, USA.

Susan R Weiss (SR)

Department of Microbiology, Perlman School of Medicine at the University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Penn Center for Research on Coronaviruses and Other Emerging Pathogens, Perlman School of Medicine at the University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.

Robert H Silverman (RH)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinicgrid.239578.2 Foundation, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH